Closed MRI Market Sees Sustained Growth

The financial momentum behind closed MRI systems is part of a larger migration of imaging services out of hospitals and into outpatient settings. Medicare pays a median of 40% more for the same service when provided in a hospital outpatient department (HOPD) versus a physician's office, a differential that has fueled the outpatient shift. Efforts toward "site-neutral payments," which would equalize this reimbursement, are gaining traction and could save Medicare and patients billions, further incentivizing freestanding imaging strategies. This site-of-care shift is prompting health systems to aggressively expand their own outpatient footprints to retain imaging revenue. In Pennsylvania, Allegheny Health Network is investing $400 million to upgrade radiology services, including a new $50 million diagnostic imaging center at its West Penn Hospital. Similarly, South Carolina's Prisma Health recently opened two outpatient imaging centers to improve patient access and offer lower-cost services. Consolidation among imaging center operators is accelerating as private equity and large providers pursue scale. RadNet, a major national provider, has spent over $54 million on acquisitions in 2024 alone, expanding into Houston and strengthening its California presence. Meanwhile, Akumin was acquired by private equity firm Stonepeak for $130 million in February 2024, a move that eliminated $470 million of its debt and took the company private to stabilize its financial future after its own significant acquisition of Alliance HealthCare Services in 2021. The competitive landscape for equipment manufacturers remains dominated by a few key players. Siemens Healthineers leads the market, followed by GE HealthCare and Philips. These companies are increasingly focused on innovations like helium-free magnet designs to reduce operating costs and integrating AI-powered image reconstruction to speed up acquisitions and increase patient throughput. Technology, particularly artificial intelligence, is rapidly reshaping radiology operations beyond the scanner itself. The FDA's list of approved AI/ML-enabled medical devices has grown to 882, with nearly 80% of them focused on medical imaging. These tools are demonstrating significant efficiency gains; some studies show AI integration can increase reporting efficiency by an average of 15.5%, with some radiologists completing reports up to 40% faster. Radiology groups must also navigate evolving safety and quality mandates from the American College of Radiology (ACR). The ACR Manual on MR Safety, which sets industry standards, has been updated to address new technologies and staffing models, including requirements for remote scanning operations and specific training levels for all personnel working in or near the MRI environment.